ClinicalTrials.Veeva

Menu

Retrospective Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease (RESPOND)

Merck KGaA (EMD Serono) logo

Merck KGaA (EMD Serono)

Status

Completed

Conditions

Non-Obstructive Coronary Artery Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT03584321
MS200101_0003

Details and patient eligibility

About

The study will estimate the current status of participants with non-obstructive coronary artery disease confirmed via coronary angiography.

Enrollment

1,600 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants who had typical or atypical angina symptom before Coronary Angiography examination
  • Underwent CAG between 01 Jan 2013 and 31 Dec 2015
  • Other protocol defined inclusion criteria could apply

Exclusion criteria

  • Participant with history of percutaneous coronary intervention or coronary artery bypass surgery
  • Participant with history of myocardial infarction
  • Participant with history of cardiac transplant or valve surgery
  • Presenting with Acute myocardial infarction for coronary angiography
  • CAG showed myocardial bridge and coronary stenosis greater than or equal to 50 percent during systole period
  • Incomplete or missing data in CAG report
  • Other protocol defined exclusion criteria could apply

Trial design

1,600 participants in 1 patient group

Participants with Coronary Artery Disease
Description:
Participants with suspected or confirmed coronary artery disease who underwent coronary angiography during 01 Jan 2013 and 31 Dec 2015 will be observed in the study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems